Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11816645 | 0.86 | KCNN4 (0.38) | KCNN4ALDH1A1TSHRMAPK1KIF11 | |
| SCHEMBL3901972 | 0.76 | KCNN4 (0.39) | KCNN4ALDH1A1TSHRMAPK1KIF11 | |
| SCHEMBL1243336 | 0.73 | MAPK1 (0.50) | KCNN4ALDH1A1TSHRMAPK1TAAR1 | |
| SCHEMBL8210946 | 0.73 | KCNN4 (0.43) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL7206964 | 0.71 | KCNN4 (0.47) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL7751653 | 0.71 | KCNN4 (0.41) | KCNN4ALDH1A1TSHRMAPK1KIF11 | |
| SCHEMBL8178 | 0.69 | KCNN4 (0.53) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL230628 | 0.69 | KCNN4 (0.53) | KCNN4ALDH1A1TSHRMAPK1CYP1A2 | |
| SCHEMBL8973 | 0.69 | KIF11 (0.48) | KCNN4ALDH1A1TSHRMAPK1KIF11 | |
| SCHEMBL297786 | 0.69 | MAPK1 (0.52) | KCNN4ALDH1A1TSHRMAPK1KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 356 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12338326-B2 | Polyamides with pendent optical absorbers and related methods | XEROX CORPORATION (US) | 2025-06-24 | — | — | US | claimed |
| CN-112457487-B | Polyamide with overhanging optical absorbers and related methods | 施乐公司 | 2024-10-01 | — | — | CN | claimed |
| CN-116463159-B | Antioxidant additive, preparation method and application thereof | 中国石油天然气股份有限公司 | 2024-07-23 | — | — | CN | claimed |
| US-20230374218-A1 | POLYAMIDES WITH PENDENT OPTICAL ABSORBERS AND RELATED METHODS | XEROX CORPORATION (US) | 2023-11-23 | — | — | US | claimed |
| US-11753505-B2 | Polyamides with pendent optical absorbers and related methods | XEROX CORPORATION (US) | 2023-09-12 | — | — | US | claimed |
| CN-114230740-B | Transparent impact-resistant styrene-butadiene resin and preparation method and application thereof | 广东众和高新科技股份公司 | 2023-09-08 | — | — | CN | claimed |
| CN-116463159-A | Antioxidant additive, preparation method and application thereof | 中国石油天然气股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-111320542-B | Antioxidant containing double hindered phenol structures and preparation method thereof | 中国石油天然气股份有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-111925285-A | Preparation method of 7-phenyl-6-heptynoic acid | 上海北卡医药技术有限公司 | 2020-11-13 | — | — | CN | claimed |
| CN-111320542-A | Antioxidant containing double hindered phenol structure and preparation method thereof | 中国石油天然气股份有限公司 | 2020-06-23 | — | — | CN | claimed |
| CN-111154092-A | Synthesis method of novel hyperbranched polyether based on sucrose as substrate | 南京尚勤新材料科技有限公司 | 2020-05-15 | — | — | CN | claimed |
| CN-109593066-A | A kind of antifol and its preparation and application for treating enterobacterial infection | 上海交通大学 | 2019-04-09 | — | — | CN | claimed |
| US-7393956-B2 | Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-01 | — | — | US | claimed |
| EP-0511001-A2 | Ring-closure method for 1-carbacephalosporin six-membered ring | ELI LILLY AND COMPANY (US) | 1992-10-28 | — | — | EP | claimed |
| US-5089610-A | Reacting with a strong base, anhydrous conditions, inert solvent, dehydrating | ELI LILLY AND COMPANY (US) | 1992-02-18 | — | — | US | claimed |
| US-4307232-A | Preparation of dialkyl- and diarylphosphonoalkanoic acids and substituted acrylic acids | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-12-22 | — | — | US | claimed |
| US-12590219-B2 | Phenol compound, conductive paste composition, method for producing conductive paste composition, conductive wire, and method for producing conductive wire | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| US-12338326-B2 | Polyamides with pendent optical absorbers and related methods | XEROX CORPORATION (US) | 2025-06-24 | — | — | US | disclosed |
| US-3974111-A | Polymeric alkoxides based on hydroxyalkyl methacrylates and a method for their preparation | CESKOSLOVENSKA AKADEMIE VED (CS) | 1976-08-10 | — | — | US | disclosed |
| US-3953438-A | Preparation of cephalosporin ethers | ELI LILLY AND COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590219-B2 | Phenol compound, conductive paste composition, method for producing conductive paste composition, conductive wire, and method for producing conductive wire | PYCARD, NPR1, TNNC1 | KCNN4 96/4885ALDH1A1 1586/4885TSHR 1553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.